Brevan Howard Capital Management LP Haemonetics Corp Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Haemonetics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 24,810 shares of HAE stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,810
Previous 4,920
404.27%
Holding current value
$1.59 Million
Previous $395,000
390.38%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
348Shares Held
55.7MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$381 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$331 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$283 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$271 Million0.07% of portfolio
-
Wellington Management Group LLP Boston, MA3.94MShares$252 Million0.06% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.28B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...